Previous 10 | Next 10 |
Shares of Fluidigm (NASDAQ: FLDM) were soaring 14.6% higher as of 10:55 a.m. EDT on Tuesday. The jump marked the second consecutive day of double-digit gains for the medical device stock. Fluidigm's momentum appears to be related to the expanding opportunities for use of the company's system...
Fluidigm Corporation (FLDM) Q1 2020 Earnings Conference Call May 7, 2020 17:30 ET Company Participants Agnes Lee - Vice President, Investor Relations Chris Linthwaite - President & Chief Executive Officer Vikram Jog - Chief Financial Officer Conference Call Participants ...
Image source: The Motley Fool. Fluidigm (NASDAQ: FLDM) Q1 2020 Earnings Call May 07, 2020 , 5:30 p.m. ET Operator Continue reading
The following slide deck was published by Fluidigm Corporation in conjunction with their 2020 Q1 earnings Read more ...
AG Mortgage Investment Trust (NYSE: MITT ) -36% . More news on: AG Mortgage Investment Trust, Inc., NantHealth, Inc., Fluidigm Corporation, Stocks on the move, , Read more ...
Fluidigm (NASDAQ: FLDM ): Q1 Non-GAAP EPS of -$0.13 misses by $0.03 ; GAAP EPS of -$0.23 misses by $0.04 . More news on: Fluidigm Corporation, Earnings news and commentary, Tech stocks news, Read more ...
First Quarter Revenue Decreased 8 Percent to $27.6 Million New COVID-19 Opportunities for Microfluidics and Mass Cytometry Businesses Customers filing FDA Emergency Use Authorization for Ultrahigh-Throughput COVID-19 Tests on the BioMark platform Maxpar Direct Immune P...
Custom Projects and Consultation from Experimental Panel Design to Data Analysis Providing Instrument Access Prior to Purchase Decision and Much‑Needed Capacity for Customers Affected by COVID-19 Related ...
Are These On Your List Of Penny Stocks To Watch In May 2020? Regardless of which names are on your list of penny stocks , this week will be an interesting one. While the coronavirus captivated headlines most of this year, China trade could be a focus for the broader markets. Last week, Pre...
Fluidigm ( FLDM +54.0% ), fresh off of a volatility halt, is up on more than triple normal volume clearing a five-week base in apparent response to an article in The Guardian about a DARPA-funded COVID-19 assay that can potentially identify carriers before they become infectious. Mor...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...